Full Press Release Details
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone Accessibility Statement Skip Navigation --> -->
JNJ
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone Johnson & Johnson (NYSE: JNJ) today announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine...
Key Takeaway: Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone Accessibility Statement Skip Navigation --> -->